missing translation for 'onlineSavingsMsg'
Learn More

Cilostazol Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111015394
Change view
Click to view available options
Quantity:
1 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
111015394 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 111015394 Supplier Merck Emd Millipore Supplier No. PHR15031G
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Cilostazol is a dihydro-quinolinone derivative, that is predominantly used as an anti-platelet and vasodilatory agent. It acts by inhibition of cyclic adenosine monophosphate (cAMP) phosphodiesterase, which results in elevation of cAMP levels in platelets and blood vessels, thus inhibiting platelets aggregation. Featured Industries: Pharmaceutical (small molecule)

Specifications

CAS 73963-72-1
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C20H27N5O2
MDL Number MFCD00866780
Synonym Cilostazol; 6-[4-(1-Cyclohexyl-1 H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1 H)-quinolinone; OPC 13013; OPC 21; Pletaal
Type Certified Reference Material
Quantity 1 g
Formula Weight 369.46
Grade Certified Reference Material